In this thesis, we have investigated a specific type of T cell, the γδT cell, and its potential as an immunotherapy against cancer. We aimed to improve current γδT cell-based therapies and demonstrate ...

When immune cells strike, precision is everything. New research reveals how natural killer and T cells orchestrate the ...

Scientists have found a way to transform hard-to-treat tumors into targets for the immune system. Using two protein stimulators, they activated strong T-cell and B-cell responses and built immune ...

When immune cells strike, precision is everything. New research reveals how natural killer and T cells orchestrate the ...

In the fight against cancer, immunotherapy—which aims to boost the body's natural defenses against cancer—is experiencing remarkable growth. Most of these treatments are based on CD8 T lymphocytes, ...

Multiple sclerosis, which affects around one in 500 people in Switzerland, is an autoimmune disease in which immune cells ...

Johns Hopkins scientists discovered a way to convert “immune-cold” tumors into “immune-hot” ones by activating key immune ...

In the fight against cancer, immunotherapy - which aims to boost the body's natural defences against cancer - is experiencing remarkable growth. Most of these treatments are based on CD8 T lymphocytes ...

Killer immune cells destroy cancer cells and cells infected by virus. These CD8 + T cells are activated after detection of viral infection or growth of “non-self” tumor cells. However, in chronic ...

New research found that gene therapy for children with a form of severe combined immunodeficiency was successful in 95% of ...